BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 32804142)

  • 1. Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease.
    Ciminelli BM; Menduti G; Benussi L; Ghidoni R; Binetti G; Squitti R; Rongioletti M; Nica S; Novelletto A; Rossi L; Malaspina P
    J Alzheimers Dis; 2020; 77(1):301-311. PubMed ID: 32804142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Genetic Association of the ABAT Gene with Alzheimer's Disease.
    Zheng Q; Bi R; Xu M; Zhang DF; Tan LW; Lu YP; Yao YG
    Mol Neurobiol; 2021 May; 58(5):1894-1903. PubMed ID: 33404980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
    Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
    Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.
    Yokoyama JS; Bonham LW; Sears RL; Klein E; Karydas A; Kramer JH; Miller BL; Coppola G
    BMC Neurol; 2015 Mar; 15():47. PubMed ID: 25880661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
    Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
    Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients.
    Scola L; Licastro F; Chiappelli M; Franceschi C; Grimaldi LM; Crivello A; Colonna-Romano G; Candore G; Lio D; Caruso C
    Aging Clin Exp Res; 2003 Aug; 15(4):292-5. PubMed ID: 14661818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
    Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
    Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
    PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of complement factor H Y402H gene polymorphism with Alzheimer's disease.
    Zetterberg M; Landgren S; Andersson ME; Palmér MS; Gustafson DR; Skoog I; Minthon L; Thelle DS; Wallin A; Bogdanovic N; Andreasen N; Blennow K; Zetterberg H
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):720-6. PubMed ID: 18163432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the ABCA7 rs3752246 polymorphism in Alzheimer's disease.
    Fehér Á; Juhász A; Pákáski M; Janka Z; Kálmán J
    Psychiatry Res; 2019 Sep; 279():376-377. PubMed ID: 30717989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
    Shi Z; Yu H; Wu Y; Ford M; Perschon C; Wang C; Zheng SL; Xu J
    Clin Genet; 2019 Feb; 95(2):302-309. PubMed ID: 30460685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers.
    Montesanto A; Crocco P; Anfossi M; Smirne N; Puccio G; Colao R; Maletta R; Passarino G; Bruni AC; Rose G
    J Alzheimers Dis; 2016; 51(4):1265-74. PubMed ID: 26923023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.
    Chung SJ; Kim MJ; Kim YJ; Kim J; You S; Jang EH; Kim SY; Lee JH
    J Neurol Sci; 2014 Apr; 339(1-2):91-6. PubMed ID: 24530172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
    Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.